📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: SeQure Dx

1.1 - Company Overview

SeQure Dx Logo

SeQure Dx

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of safety data and diagnostic platforms for on- and off-target CRISPR gene editing therapies. Offers NoteSeQ (ONE-seq) for profiling off-target sites, ScopeSeQ for validating candidate edits via next-generation sequencing, risk assessment across the development lifecycle, discovery/IND support, clinical trial patient risk management, and post-approval diagnostic management with patient and physician education.

Products and services

  • Gene Editing Off-Target Risk Assessment: CRISPR-focused service that assesses and identifies on-target specificity and off-target risks throughout the gene editing therapeutic development lifecycle, delivering safety data for therapy development
  • NoteSeQ: Assay-based diagnostic platform utilizing ONE-seq to profile off-target gene editing sites across a range of gene editors, generating safety data for therapeutic decision-making
  • ScopeSeQ: NGS-driven confirmation platform validating candidate off-target edits in individual genomes or tissues using next-generation sequencing, supporting verification of edit specificity during CRISPR therapy development

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to SeQure Dx

Crescendo Bioscience Logo

Crescendo Bioscience

HQ: United States Website
  • Description: Provider of quantitative, objective diagnostic tools for rheumatologists, delivering clinical insights to manage patients with autoimmune and inflammatory diseases. Provides diagnostic, prognostic, staging, therapy selection, and monitoring facilities to physicians.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Crescendo Bioscience company profile →
Phthisis Diagnostics Logo

Phthisis Diagnostics

HQ: United States Website
  • Description: Provider of molecular diagnostics products for various infectious diseases, leveraging molecular technology to deliver superior quality, ease of use, and cost savings for laboratories.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Phthisis Diagnostics company profile →
Rewrite Therapeutics Logo

Rewrite Therapeutics

HQ: United States Website
  • Description: Provider of novel DNA writing technologies from a private biotechnology company focused on advancing the field.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Rewrite Therapeutics company profile →
Ingenuity Logo

Ingenuity

HQ: United States Website
  • Description: Provider of a software platform and information services that enable enterprise customers to give life science researchers access to information via internal portals, search engines, other software, and workflow sources, allowing them to search, explore, visualize, interpret, and analyze complex biological systems.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ingenuity company profile →
Genomatix Logo

Genomatix

HQ: Germany Website
  • Description: Provider of computational biology software, databases, and services for understanding gene regulation at the molecular level, including sequence analysis, functional promoter analysis, proprietary genome annotation, and promoter sequence databases, plus testing and interpreting genomic data, representing a central part of systems biology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Genomatix company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for SeQure Dx

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to SeQure Dx

2.2 - Growth funds investing in similar companies to SeQure Dx

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for SeQure Dx

4.2 - Public trading comparable groups for SeQure Dx

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to SeQure Dx

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About SeQure Dx

What does SeQure Dx do?

SeQure Dx is a provider of safety data and diagnostic platforms for on- and off-target CRISPR gene editing therapies. Offers NoteSeQ (ONE-seq) for profiling off-target sites, ScopeSeQ for validating candidate edits via next-generation sequencing, risk assessment across the development lifecycle, discovery/IND support, clinical trial patient risk management, and post-approval diagnostic management with patient and physician education.

Who are SeQure Dx's competitors?

SeQure Dx's competitors and similar companies include Crescendo Bioscience, Phthisis Diagnostics, Rewrite Therapeutics, Ingenuity, and Genomatix.

Where is SeQure Dx headquartered?

SeQure Dx is headquartered in United States.

How many employees does SeQure Dx have?

SeQure Dx has 1,000 employees 🔒.

When was SeQure Dx founded?

SeQure Dx was founded in 2010 🔒.

What sector and industry vertical is SeQure Dx in?

SeQure Dx is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for SeQure Dx

Who are the top strategic acquirers in SeQure Dx's sector and industry

Top strategic M&A buyers and acquirers in SeQure Dx's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for SeQure Dx?

Top strategic M&A buyers groups and sectors for SeQure Dx include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in SeQure Dx's sector and industry vertical

Which are the top PE firms investing in SeQure Dx's sector and industry vertical?

Top PE firms investing in SeQure Dx's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in SeQure Dx's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in SeQure Dx's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in SeQure Dx's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to SeQure Dx include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in SeQure Dx's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for SeQure Dx?

The key public trading comparables and valuation benchmarks for SeQure Dx include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for SeQure Dx for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for SeQure Dx with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in SeQure Dx's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for SeQure Dx with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in SeQure Dx's' sector and industry vertical?

Access recent funding rounds and capital raises in SeQure Dx's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for SeQure Dx

Launch login modal Launch register modal